Human CLPB forms ATP-dependent complexes in the mitochondrial intermembrane space.

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Medicine

Background:

• Human caseinolytic peptidase B (CLPB), also known as suppressor of potassium transport defect 3 (SKD3), is an ATPase associated with diverse cellular activities (AAA+).
• CLPB mutations cause 3-methylglutaconic aciduria type VII, and CLPB is upregulated in acute myeloid leukemia (AML), contributing to drug resistance.
• The precise biological function and clinical links of CLPB remain largely unknown.

Purpose of the Study:

• To investigate the subcellular localization and biochemical properties of human CLPB.
• To elucidate the role of ATP in CLPB function and complex formation.
• To understand the mechanistic basis of CLPB's involvement in disease.

Main Methods:

• Subcellular fractionation and immunofluorescence microscopy in HEK-293 and BT-549 cells.
• Mitochondrial purification and proteinase K protection assays.
• Blue native polyacrylamide gel electrophoresis (BN-PAGE) to analyze protein complexes.

Main Results:

• CLPB was localized to the mitochondrial intermembrane space, protected from proteinase K in intact mitochondria.
• Overexpressed CLPB formed detergent-resistant aggregates within mitochondria.
• Endogenous CLPB formed high molecular weight complexes in an ATP-dependent manner.

Conclusions:

• CLPB resides in the mitochondrial intermembrane space.
• ATP binding induces structural changes in CLPB, regulating its self-association and complex formation.
• These findings provide insights into CLPB's function and its potential role in AML drug resistance.